Skip to main content

Table 2 Coefficients and marginal effects for a dichotomous change in keratinocyte cancer (KC)

From: A reconstruction of a medical history from administrative data: with an application to the cost of skin cancer

Variables

Coefficient

p -value

Marginal effect of KC

Covariates held constant for calculation of marginal effects

n

Keratinocyte cancer (=0/1)

0.36

<0.01

666.5

all covariates @ mean

 

Other medical treatment

     

Treated for other disease (=0/1)

−0.27

0.01

556

=1 & residual @ mean

 

Treated for melanoma (=0/1)

0.40

<0.01

988

=1 & residual @ mean

53

Treated for hypertension (=0/1)

0.09

0.15

719

=1 & residual @ mean

645

Treated for hyperlipidaemia (=0/1)

0.04

0.55

686

=1 & residual @ mean

1036

Treated for cardiovascular disease (=0/1)

0.56

0.00

953

=1 & residual @ mean

1342

Treated for diabetes (=0/1)

0.16

0.02

774

=1 & residual @ mean

354

Treated for breast cancer (=0/1)

0.41

<0.01

983

=1 & residual @ mean

187

Treated for colorectal cancer (=0/1)

0.36

<0.01

926

=1 & residual @ mean

279

Treated for prostate cancer (=0/1)

0.38

<0.01

952

=1 & residual @ mean

227

Treated for asthma (=0/1)

0.19

<0.01

785

=1 & residual @ mean

507

Treated for rheumatoid arthritis (=0/1)

0.30

<0.01

862

=1 & residual @ mean

546

Treated for multiple sclerosis (=0/1)

0.83

<0.01

1,522

=1 & residual @ mean

10

Treated for depression (=0/1)

0.17

<0.01

771

=1 & residual @ mean

602

Treated for anxiety (=0/1)

0.30

0.01

895

=1 & residual @ mean

118

Treated for osteoarthritis (=0/1)

0.40

<0.01

939

=1 & residual @ mean

527

Treated for Parkinson’s disease (=0/1)

0.23

0.23

840

=1 & residual @ mean

22

Treated for tuberculosis (=0/1)

0.90

< 0.01

1,626

=1 & residual @ mean

49

Treated for bronchitis (=0/1)

−0.01

0.96

663

=1 & residual @ mean

85

Medical history

     

History of hypertension (=0/1)

0.14

0.18

-

-

-

History of hyperlipidaemia (=0/1)

0.21

0.39

-

-

-

History of cardiovascular disease (=0/1)

0.01

0.85

-

-

-

History of diabetes (=0/1)

0.07

0.46

-

-

-

History of breast cancer (=0/1)

0.21

0.06

-

-

-

History of colorectal cancer (=0/1)

−0.29

0.03

-

-

-

History of prostate cancer (=0/1)

0.08

0.60

-

-

-

History of asthma (=0/1)

0.27

0.22

-

-

-

History of rheumatoid arthritis (=0/1)

0.46

0.02

-

-

-

History of multiple sclerosis (=0/1)

1.65

< 0.01

-

-

-

History of depression (=0/1)

0.04

0.75

-

-

-

History of anxiety (=0/1)

0.40

0.04

-

-

-

History of osteoarthritis (=0/1)

−0.14

0.39

-

-

-

History of Parkinson’s disease (=0/1)

0.51

0.11

-

-

-

History of tuberculosis (=0/1)

−0.15

0.62

-

-

-

History of bronchitis (=0/1)

−1.03

< 0.01

-

-

-.

Other variables

     

Female (=0/1)

−0.06

0.29

-

-

-

Age (years)

0.00

0.13

-

-

-.

Constant

6.67

< 0.01

-

-

-.

  1. Note: All reported marginal effects for keratinocyte cancer were statistically significant (p-value < 0.05).
Back to article page

Health Economics Review

ISSN: 2191-1991

Contact us